ViruBac ApS: Financial statements 2022

CVR: 41362731

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

ViruBac ApS (CVR 41362731) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -18,926 and a net result of DKK -24,025. Equity in the 2022 report amounted to DKK -75,248.

Gross Profit: DKK -18,926
Profit/Loss: DKK -24,025
Equity: DKK -75,248
Total Assets: DKK 87,394

Official annual report

View the official annual report directly on the page with a Pro subscription.

Read the original annual report at the Danish Business Authority

Keep an eye on ViruBac ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Sten Grønved Nielsen steps down as director of ViruBac ApSDec 9, 2022

As of December 9, 2022, Sten Grønved Nielsen has stepped down as director of ViruBac ApS.

About ViruBac ApS

ViruBac ApS was a Danish company of the type Anpartsselskab based in Faaborg, founded in 2020. The company has been dissolved on 9 October 2023. The company was registered under the industry Fremstilling af farmaceutiske råvarer. In 2023, the company reported a gross profit of DKK -14,804 and a net result of DKK 77,143 compared with DKK -24,025 the year before. Equity in the 2023 report amounted to DKK 1,894.

Source: annual report 2023, Danish Business Authority

Other financial years

2023